Formulation Development

EXCLUSIVE ONLINE CONTENT

1/21/2021

Nexelis Acquires GSK Vaccines Clinical Bioanalytical Laboratory

Nexelis, a portfolio company of Ampersand Capital Partners, and a leading provider of advanced assay development and laboratory testing services in the infectious, oncologic, and metabolic diseases fields, has signed an asset purchase agreement with GSK to….